Table 3.
Correlations Between Cognitive Impairment and Clinical Characteristics in Patients (n=48)
Time on LHRH | Type of LHRHa | Concurrent anti-androgenb | Prior prostatectomyb | Prior brachytherapyb | Prior radiotherapyb | |
---|---|---|---|---|---|---|
HLVT Immediate Recallc | .13 | −.05 | −.15 | .29* | −.09 | −.06 |
HVLT Delayed Recallc | .13 | −.04 | −.12 | .35* | −.27 | .11 |
BVMT Immediate Recallc | .10 | −.05 | .05 | −.01 | .14 | −.06 |
BVMT Delayed Recallc | .01 | −.20 | .08 | −.04 | .23 | −.18 |
COWA Totalc | −.10 | −.05 | .05 | .09 | .25 | .04 |
Symbol Digit Items Completedc | −.08 | −.08 | −.08 | −.11 | .01 | −.03 |
Card Rotations Testc | -- | -- | -- | -- | -- | -- |
Overall Impairmentc | −.02 | .04 | −.04 | .22 | .03 | −.09 |
Number of Impaired Tests – M (SD) | .06 | −.13 | −.04 | .18 | .08 | −.05 |
0= leuprolide, 1= goserelin,
0=no, 1=yes,
0=no impairment, 1=impairment
p<.05